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Up-regulation of kidney NAD(P)H oxidase and calcineurin in
SHR: Reversal by lifelong antioxidant supplementation.
Background. Spontaneously hypertensive rats (SHR) are
born normotensive and develop hypertension (HTN) later in
life (age 4 to 5 weeks). HTN in SHR is associated with and
caused in part, by oxidative stress and renal interstitial in-
flammation. This study tested the hypothesis that lifelong an-
tioxidant supplementation beginning at prenatal period may
delay the onset and reduce the severity of HTN in SHR.
The study further sought to explore the effect of diet mod-
ification on renal tissue NAD(P)H oxidase and calcineurin
abundance.
Methods. Pregnant SHR and their offspring were fed either
an antioxidant-fortified diet (a chow containing a-tocopherol
5000 IU/kg, ascorbic acid 500 ppm, selenium 2.76 ppm, and
zinc 350 ppm) or regular diet (a-tocopherol 40 IU/kg, selenium
0.2 ppm, and zinc 70 ppm). Animals were observed for 24 weeks.
Wistar-Kyoto rats fed either a regular or antioxidant diet served
as control.
Results. Onset of HTN was delayed and severity of HTN was
reduced in antioxidant-treated compared with untreated SHR.
Markers of oxidative stress (i.e., plasma hydrogen peroxide,
renal tissue malondialdehyde, and nitrotyrosine abundance)
were elevated in untreated but not in antioxidant-treated
SHR. gp91phox and p22phox subunits of NAD(P)H oxidase were
markedly elevated in the renal cortex of untreated SHR and par-
tially restored in the treated SHR. Similarly, renal calcineurin
Aa and B subunits were elevated in untreated SHR and were
partially restored in the treated SHR. Antioxidant therapy had
no effect on the measured parameters in the WKY control.
Conclusion. Lifelong consumption of antioxidant-rich diet
ameliorates HTN and oxidative stress in SHR. This is asso-
ciated with the reduction of superoxide-generating enzyme,
NAD(P)H oxidase, and immunoregulatory factor calcineurin.
Antioxidant-rich diet appears to attenuate oxidative stress, not
only by fortifying antioxidant defense capacity but also by low-
ering NAD(P)H oxidase, which is a major source of reactive
oxygen species.
Key words: oxidative stress, hypertension, NAD(P)H oxidase, cal-
cineurin, kidney.
Received for publication April 8, 2003
and in revised form August 7, 2003
Accepted for publication August 14, 2003
C© 2004 by the International Society of Nephrology
Spontaneously hypertensive rats (SHR) were origi-
nally developed by Okamoto and Aorki [1] from brother-
sister inbreeding of Wistar-Kyoto (WKY) rats with a pair
of outbred female and male WKY rats, which exhibited
mild elevation of arterial pressure. SHR are frequently
used as a model of essential hypertension (HTN) in hu-
mans. As in humans with essential HTN, the SHR are
born normotensive and develop HTN later in life, begin-
ning at 4 to 5 weeks of age. HTN in SHR and various
other models of hereditary and acquired HTN is associ-
ated with increased production of reactive oxygen species
(ROS) [2–24]. ROS can raise arterial pressure via inac-
tivation of nitric oxide, generation of isoprostanes, and
cardiovascular remodeling. In fact, amelioration of ox-
idative stress by a variety of antioxidant regimens has
been shown to attenuate HTN in various hypertensive
disorders [13–25].
ROS are generated by mitochondria during the cellu-
lar respiration and as byproducts of specific oxidases in
the cytoplasm. In addition, under pathologic conditions,
large quantities of ROS are produced by activated leuko-
cytes, macrophages, and various other cell types. The pri-
mary ROS generated in the cell is superoxide. Nicoti-
namide adenine dinucleotide (phosphate) [NAD(P)H]
oxidase, which was originally found in phagocytes, is
the major source of superoxide in various other tis-
sues [26]. The enzyme consists of at least five pro-
tein subunits, namely gp91phox and p22phox, which are
membrane associated, and p47phox, p67phox and p40phox,
which reside in the cytosol of resting cells [27]. Vari-
ous components of phagocyte NAD(P)H oxidase have
also been identified in other cells [26–28], including en-
dothelial cells, vascular smooth muscle cells (VSMCs),
and fibroblasts. In addition, all NAD(P)H oxidase sub-
units have been demonstrated in the rat kidney [29,
30]. NAD(P)H oxidase is up-regulated by various stim-
uli including shear stress, cyclic strain, and humoral
factors such as angiotensin II and proinflammatory
cytokines, which can be targeted by specific pharma-
cologic interventions to ameliorate oxidative stress and
HTN [31].
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Several recent studies have demonstrated interstitial
accumulation of superoxide-producing activated T lym-
phocytes and macrophages in the SHR kidney [25, 33].
While the contribution of the activated T cells and
macrophages to the associated oxidative stress is clear,
the mechanism responsible for their activation and accu-
mulation in the renal interstitium is not fully understood.
In this regard, Nava et al [25] recently demonstrated
significant activation of nuclear transcription factor
kappa B (NFjB) in SHR kidney. This event can,
in part, contribute to activation and accumulation of
inflammatory cells by promoting production of proin-
flammatory cytokines. Calcineurin and its downstream
signal molecule, nuclear factor of activated T cell
(NFAT), are essential for production of interleukin-2
(IL-2), which plays an important role in lymphocyte acti-
vation and generation of other inflammatory cytokines
[34]. Thus, calcineurin may potentially contribute to
the previously reported interstitial accumulation of im-
munocompetent lymphocytes and macrophages in SHR
kidney.
The present study tested the hypothesis that lifelong
supplementation of an antioxidant-fortified diet begin-
ning at prenatal life may delay the onset and attenuate the
severity of HTN. The study further sought to investigate
the effect of antioxidant-rich diet on NAD(P)H oxidase
and calcineurin abundance in untreated and antioxidant-
treated SHR.
METHODS
Animal experiments
SHR and control Wistar-Kyoto rats (WKY) were
obtained from Charles River Laboratories (Hollister,
CA, USA). One-week pregnant rats were fed either a
regular rodent laboratory diet containing a-tocopherol
(40 IU/kg), selenium (0.2 ppm), and zinc (70 ppm),
or an antioxidant-rich diet prepared by adding a-
tocopherol (5000 IU/kg), ascorbic acid (500 ppm), sele-
nium (2.76 ppm), and zinc (350 ppm) to the regular diet
(Purina Mills, Inc., Richmond, IN, USA). The offspring
were continued on the respective diets for 24 weeks.
WKY rats, fed regular diet, served as control. Only male
offspring were included in the present study. To de-
termine the effect of the given antioxidant regimen in
the normotensive animals, male WKY rats fed either a
regular or antioxidant-fortified diets were included in
the study. The animals were housed in a temperature-
controlled UC Irvine Vivarium with 12-hour light and
dark cycles and were given unrestricted access to food
and water throughout the observation period. Twenty-
four-hour urine collections were obtained using individ-
ual metabolic cages. The protocol employed in this study
was approved by the Institutional Animal Care and Use
Committee of the University of California, Irvine.
At the end of the experiments, animals were anes-
thetized with intraperitoneal injections of pentobarbital
sodium (50 mg/kg). Blood was collected by cardiac punc-
ture, kidneys were removed immediately, snap-frozen in
liquid nitrogen, and stored at −70◦C until processed. Uri-
nary protein, serum and urine creatinine concentrations
were determined by kits purchased from Sigma Chemical
Co. (St. Louis, MO, USA).
Plasma hydrogen peroxide. Plasma H2O2 concentra-
tion was determined by the quantitative H2O2 assay kit
purchased from OXIS International, Inc. (Portland, OR,
USA).
Tissue malondialdehyde (MDA). Renal MDA content
was determined in kidney supernatants as described by
the Buege and Aust [35].
Blood pressure determinations
Blood pressure was determined by tail-cuff plethys-
mography (Harvard Apparatus, Inc., Natick, MA, USA)
as described previously [36]. Conscious rats were placed
on a heated pad in a temperature-controlled quiet room.
After 15 minutes rest with the tail placed inside a tail
cuff, the cuff was inflated 3 to 4 times to condition the an-
imal to the procedure. Four consecutive measurements
were then taken and the average of the recorded mea-
surements was used.
Western blot analysis
Homogenates (20% w/v) of renal cortex and medulla
were prepared in 10 mmol/L HEPES buffer, pH 7.4,
containing 320 mmol/L sucrose, 1 mmol/L EDTA,
1 mmol/L DTT, 10 lg/mL leupeptin, 2 lg/mL aprotinin,
and 1 mmol/L PMSF at 0 to 4◦C using a homogenizer.
Homogenates were centrifuged at 9000g for 10 minutes at
4◦C to remove nuclear fragments and tissue debris with-
out precipitating membrane fragments. A portion of the
supernatant was used for the determination of total pro-
tein concentration by using a BioRad kit (Hercules, CA,
USA).
Total cellular protein (20 lg each) was electrophoresed
in 4%–20% Tris-glycine sodium dodecyl sulphate (SDS)
polyarcrylamide gels (Novex, San Diego, CA, USA).
Proteins were transferred onto polyvinylidene fluoride
(PVDF) membranes (Millipore Corp., Bedford, MA,
USA), blocked in 5% dry milk in T-TBS (0.02 mol/L
Tris/0.15 mol/L NaCl, pH 7.5 containing 0.1% Tween
20) at room temperature for 3 hours, washed 3 times
with T-TBS, and incubated with the primary antibody
(the antibodies were diluted 1:1000 for p22phox, gp91phox,
p47phox, p67phox, calcineurin B, and nitrotyrosine, 1:2000
for calcineurin Aa) for 3 hours at room temperature. The
primary antibody for gp91phox subunit of NADPH oxi-
dase was purchased from Transduction Labs (Lexington,
KY, USA). The p22phox polyclonal, p47phox, and p67phox
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Table 1. Body weight, urinary creatinine clearance, and protein
excretion in WKY rats and SHR groups given regular diet (SHR-R)
or antioxidant-fortified diet (SHR-T)
WKY SHR-R SHR-T
Body weight g 341 ± 9.8 345 ± 10.7 327 ± 8.5
Creatinine clearance mL/min 1.23 ± 0.27 1.03 ± 0.20 1.25 ± 0.19
Urinary protein mg/24 h 26.9 ± 4.9 38.6 ± 6.2a 39.9 ± 6.3a
N = 6 in each group.
aP < 0.05 vs. WKY group.
monoclonal antibodies were generously supplied by
Dr. Mark T. Quinn, Montana State University, Bozema,
MT. Nitrotyrosine (clone 1A6), calcineurin/PP2B Aa
polyclonal, and calcineurin/PP2B B (clone VA1) were
purchased from Upstate (Lake Placid, NY, USA). Af-
ter washing 5× with T-TBS, the blots were incubated
with secondary antibody (1:1000; antimouse for gp91phox,
p47phox, p67phox, calcineurin/PP2B B, and nitrotyrosine;
antirabbit for p22phox and calcineurin/PP2B Aa) conju-
gated with horseradish peroxidase at room temperature
for 2 hours. After washing 5× with T-TBS, the membrane
was developed using ECL reagent (Amersham Life Sci-
ence, Inc., Buckinghamshire, UK) and subjected to auto-
luminography for 1 to 5 minutes. The autoluminographs
were scanned with a laser densitometer (Model PD 1211,
Molecular Dynamics, Sunnyvale, CA, USA) to determine
the relative optical densities of the bands.
Statistical analysis
All values shown are mean ± SE. Comparisons be-
tween groups were done using one-way analysis of vari-
ance (ANOVA) and least significant difference (LSD)
test. Differences were considered statistically significant
when P < 0.05.
RESULTS
General data
Data are summarized in Table 1. There was no signifi-
cant difference in body weights among the study groups.
Mean creatinine clearance in the untreated SHR was
insignificantly lower than that found in the WKY and
antioxidant-treated SHR groups. Urinary protein excre-
tion was significantly increased in both SHR groups as
compared to the WKY control group.
Arterial pressure data
Data are shown in Figure 1. Significant HTN was
present in the untreated SHR but not in the antioxidant-
treated SHR at age 6 weeks. Arterial pressure remained
virtually unchanged in the WKY group throughout the
study period, but rose steadily in the SHR groups. How-
ever, arterial pressure values were consistently lower
in the antioxidant-treated than in the untreated SHR
throughout the study period.
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Fig. 1. Systolic blood pressure in Wistar Kyoto (WKY) rats and spon-
taneously hypertensive rat (SHR) groups raised on a regular diet (SHR-
R) or antioxidant-fortified diet (SHR-T) obtained at age 6, 8, 12, and
24 weeks. N = 6 in each group, P < 0.05, ∗ SHR-R or SHR-T vs. WKY,
# SHR-R vs. SHR-T.
Markers of oxidative stress
Data are illustrated in Figure 2. The untreated SHR
group showed a significant increase in plasma H2O2 con-
centration as compared to the WKY control rats. An-
tioxidant therapy prevented the rise in plasma H2O2 in
the treated SHR. The untreated SHR exhibited a signifi-
cant elevation of kidney tissue nitrotyrosine abundance,
denoting increased NO inactivation and protein oxida-
tion by ROS. Antioxidant therapy led to normalization
of kidney tissue nitrotyrosine content. In addition, mal-
ondialdehyde (MDA) content in the kidney tissue was
higher in the untreated SHR compared with the WKY
and the treated SHR groups. However, the difference
did not reach statistical significance.
Kidney NAD(P)H oxidase
Data are depicted in Figure 3. The untreated SHR ex-
hibited a marked increase in immunodetectable gp91phox
and p22phox subunits of NAD(P)H oxidase in the renal
cortex compared with those in the WKY control. The up-
regulation of these membrane-associated subunits was
partially but significantly attenuated by chronic antioxi-
dant therapy. No significant difference was found in the
intracellular p47phox and p67phox subunits of NAD(P)H
oxidase among the study groups.
Protein expression of NAD(P)H oxidase subunits in
renal medulla was comparable among the three groups
(data not shown).
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Fig. 2. (A) Renal nitrotyrosine abundance,
(B) renal malondialdehyde content, (C) and
plasma hydrogen peroxide concentration in
Wistar Kyoto (WKY) rats and spontaneously
hypertensive rat (SHR) groups raised on a
regular diet (SHR-R) or antioxidant-fortified
diet (SHR-T). N = 6 in each group, ∗P < 0.05.
Kidney calcineurin
Data are presented in Figure 4. Protein abundance of
both calcineurin Aa and B subunits was significantly in-
creased in the renal cortex of the untreated SHR com-
pared with those found in the WKY controls. Long-term
consumption of antioxidant-fortified diet normalized
protein abundance of calcineurin Aa subunit, and
partially attenuated the up-regulation of calcineurin
B subunit.
Expression of calcineurin subunits in renal medulla was
comparable in the three groups (data not shown).
Effect of antioxidant therapy in WKY rats
Data are shown in Figures 5 and 6. Antioxidant therapy
had no effect on either systolic arterial pressure (125 ± 1.5
vs. 124 ± 1.8 mm Hg), body weight (315 ± 5 and 318 ± 3 g
in untreated and treated groups, respectively), renal tis-
sue nitrotyrosine, gp91phox, p47phox, p67phox, calcineurin
Aa or B subunits.
DISCUSSION
Lifelong consumption of the antioxidant-fortified diet
beginning at the prenatal period delayed the onset and
attenuated the severity of HTN in the SHR born in our
facility and observed for 6 months. The beneficial ef-
fect of lifelong consumption of the antioxidant-rich diet
shown here extends the results of short-term administra-
tion of the antioxidant drugs, including tempol, lazaroid,
and melatonin in the adult SHR [15, 23, 25]. It should be
noted that administration of antioxidant agents does not
affect blood pressure in normal animals in whom oxida-
tive stress is absent [9, 10, 11, 22, 23]. Together, these ob-
servations confirm the contribution of oxidative stress to
the pathogenesis and maintenance of HTN in this model.
In fact, the SHR group consuming regular diet exhib-
ited significant elevations of plasma hydrogen peroxide,
as well as kidney tissue nitrotyrosine and MDA, denoting
the presence of oxidative stress. Elevation of nitrotyro-
sine and lipoperoxides in the SHR kidney observed here
is consistent with the results of earlier studies of Bapat
et al [37] and Zhou et al [38]. In contrast, the levels of
these markers of oxidative stress were nearly normal in
the SHR consuming antioxidant-fortified diet. This obser-
vation points to the efficacy of the antioxidant mixture
(a-tocopherol, ascorbic acid, zinc, and selenium) em-
ployed in the present study. The choice of these nutrients
was based on their natural origin, ready availability, low
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Fig. 3. Representative Western blots and
group data depicting gp91phox , p22phox ,
p47phox , and p67phox subunit of NAD(P)H
oxidase in the renal cortex of Wistar Kyoto
(WKY) rats and spontaneously hypertensive
rat (SHR) groups raised on a regular diet
(SHR-R) or antioxidant-fortified diet (SHR-
T). N = 6 in each group, ∗P < 0.05 and ∗∗P <
0.01, ∗∗∗P < 0.001.
toxicity, and demonstrated efficacy in various models of
HTN [9–11, 39, 40].
Oxidative stress in the SHR consuming regular diet
was accompanied by significant up-regulation of gp91phox
and p22phox, which represent the membrane-associated
subunits of NAD(P)H oxidase. The elevation of kidney
gp91phox and p22phox abundance in the untreated SHR
was associated with a parallel increase in kidney tissue
nitrotyrosine, which is generally viewed as a footprint
of superoxide interaction with nitric oxide. The latter
observation provides functional evidence for increased
superoxide production in the kidney of untreated SHR
presumably by NAD(P)H oxidase. These observations
are consistent with the results of the elegant studies of
Chabrashvili et al [29], who recently demonstrated signif-
icant up-regulations of NAD(P)H oxidase and its other
isotypes, NOX-1 and NEPHROX, in the SHR kidney.
The functional significance of up-regulations of these
superoxide-producing enzymes in the kidney is evidence
by overabundance of superoxide positive cells in SHR
kidney [25]. Amelioration of oxidative stress by lifelong
consumption of antioxidant-fortified diet was associated
with significant reductions of gp91phox and p22phox abun-
dance in the renal cortex of antioxidant-treated com-
pared to the untreated SHR. Accordingly, in addition
to direct scavenging of ROS, antioxidant regimen em-
ployed here appears to limit production of ROS by
lowering NAD(P)H oxidase abundance in the kidney.
The latter finding is consistent with the recent report
by Chen et al [19], who found significant reduction of
kidney NAD(P)H oxidase activity by administration of
vitamins E and C in stroke-prone SHR. The authors at-
tributed this phenomenon to inhibition or interruption of
complex formation of NAD(P)H oxidase subunits [19].
The antioxidant-treated SHR used in the present study
showed a significant reduction in the immunodetectable
gp91phox and p22phox abundance, which points to quan-
titative modification of renal NAD(P)H oxidase by an-
tioxidant supplementation. Thus, alleviation of oxidative
stress appears to limit both activation and expression of
this enzyme.
Oxidative stress can up-regulate NAD(P)H oxidase ex-
pression and promote inflammation via ROS-mediated
activation of NFjB and the resultant generation of
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Fig. 4. Representative Western blots and
group data depicting Aa and B subunit of
calcineurin in the renal cortex of Wistar Ky-
oto (WKY) rats and spontaneously hyperten-
sive rat (SHR) groups raised on a regular diet
(SHR-R) or antioxidant-fortified diet (SHR-
T). N = 6 in each group, ∗P < 0.05.
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Fig. 5. Representative Western blots and
group data depicting gp91phox, p47phox,
p67phox, and nitrotyrosine abundance in the
renal cortex of the Wistar Kyoto (WKY)
rats fed a regular (WKY-R) or antioxidant-
fortified (WKY-T) diet. N = 6 in each group,
no significant differences were found.
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nal cortex of the Wistar Kyoto (WKY) rats fed a regular (WKY-R) or
antioxidant-fortified (WKY-T) diet. N = 6 in each group, no significant
differences were found.
proinflammatory cytokines. In fact, Nava et al [25] have
recently shown marked activation of NFjB and its atten-
uation by antioxidant therapy in the SHR kidney. There-
fore, the reduction in NAD(P)H oxidase abundance in
our antioxidant-treated SHR may be due to diminished
NFFB activity.
Recent studies have demonstrated the presence
of infiltrating immunocompetent lymphocytes and
macrophages in the renal interstitium of SHR [25, 33].
Moreover, the infiltrating cells were found to be an impor-
tant source of angiotensin II and superoxide [25, 33]. By
promoting local angiotensin II production and oxidative
stress, the inflammatory cells present in the renal intersti-
tium can contribute to hypertension in SHR. This suppo-
sition is supported by several elegant studies [32, 41–43]
demonstrating amelioration of HTN and renal interstitial
inflammatory infiltration in response to administration of
the immunosuppressive agent, mycophenolate mofetil, in
SHR and several other models of HTN [32, 40–42]. The
role of immune system in the pathogenesis of HTN is
further enforced by the earlier studies of Svendsen [44],
who demonstrated that athymic nude mice were resis-
tant to the salt-dependent phase of DOCA salt–induced
HTN. Renal interstitial infiltration of T-lymphocytes and
macrophages in SHR is associated with and caused by at
least in part, activation of NFjB [25] and the resultant
generation of proinflammatory cytokines.
Calcineurin, a Ca2+-calmodulin-activated serine/
threonine phosphatase, plays an important role in
numerous cellular events involving Ca2+-calmodulin
signal transduction pathways [34]. For instance, dephos-
phorylation of NAFT by calcineurin results in activation
and translocation of NFAT from cytoplasm to nucleus,
where it binds to its DNA binding site to initiate tran-
scription and eventual production of interleukin-2 (IL-2)
[45–47]. IL-2 produced in this manner binds to IL-2
receptor to generate signals required for completion
of lymphocyte activation cascade, cell proliferation,
and generation of other proinflammatory cytokines
[45–47]. Given the critical role of calcineurin in T-cell
activation and inflammatory cascade, it is conceivable
that accumulation of activated T cells and macrophages
in SHR kidney may be, in part, mediated by calcineurin.
The present study showed marked up-regulation of both
calcineurin Aa (the catalytic subunit) and calcineurin B
(the regulatory subunit) abundance in the renal cortex of
untreated SHR. It is of interest that chronic inhibition of
calcineurin by either cyclosporine or FK506 commonly
results in HTN and oxidative stress in humans and
experimental animals [48–51]. Thus, the role, if any,
of the observed up-regulation of renal calcineurin in
the pathogenesis of HTN and oxidative stress in SHR
is uncertain and awaits investigation. Interestingly,
up-regulation of calcineurin expression in renal cortex
was partially ameliorated by long-term antioxidant sup-
plementation. This observation suggests that oxidative
stress may be involved in regulation of calcineurin in this
organ. Partial restoration of renal calcineurin expression
with antioxidant supplementation was accompanied by
a parallel reduction of NAD(P)H oxidase abundance
in the treated SHR. This observation points to possible
interdependent regulation of these enzymes.
In contrast to the SHR, which showed significant re-
ductions in blood pressure, kidney tissue nitrotyrosine,
NAD(P)H oxidase, and calcineurin abundance, the mea-
sured parameters were unaffected by antioxidant therapy
in the WKY rats. This observation is consistent with the
earlier studies and suggests that in the absence of oxida-
tive stress, antioxidant supplementation, above that con-
tained in the regular diet, has no additional impact on the
measured parameters. Despite reduction in arterial pres-
sure, proteinuria was not attenuated in the antioxidant-
treated SHR. The authors wish to point out that while
arterial pressure was significantly reduced, it was not
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normalized by antioxidant therapy, and significant, albeit
less severe HTN existed in the treated animals. Moreover,
while urinary protein excretion was significantly higher
in SHR than in WKY group, it was relatively mild. More
severe proteinuria and progressive decline in glomeru-
lar filtration rate occurs at a much later stage in SHR
[52]. Therefore, long-term studies are needed to discern
whether or not antioxidant therapy can affect develop-
ment of severe proteinuria and retard development of
renal insufficiency in the aged SHR.
CONCLUSION
Lifelong consumption of antioxidant-rich diet ame-
liorates HTN and oxidative stress in SHR. This is
associated with the reduction of NAD(P)H oxidase.
Thus, antioxidant-rich diet appears to attenuate oxidative
stress, not only by fortifying antioxidant defense capacity
but also by lowering NAD(P)H oxidase and hence, ROS-
generating capacity. Calcineurin abundance is increased
in the renal cortex and declines with antioxidant therapy
in SHR. The role of the observed alterations of the re-
nal cortical calcineurin abundance in the pathogenesis of
hypertension and its response to antioxidant therapy is
presently unknown and awaits future investigation.
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